(Q39906266)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Asim Shuja

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Idy Tam

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Eun Min Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Sandra Kang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Leonid Kapulsky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Kathleen Viveiros

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Hannah Lee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

publication date

18 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

11 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

2236-2241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10620-016-4118-1

11 March 2020

exact match

0 references

cites work

Hepatitis B virus infection in US correctional facilities: a review of diagnosis, management, and public health implications

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Low rates of hepatitis B virus screening at the onset of chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

The efficacy of lamivudine prophylaxis against hepatitis B reactivation in breast cancer patients undergoing chemotherapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

The impact of hepatitis screening on diagnosis and treatment in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Screening prior to biological therapy in Crohn's disease: adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Low level of hepatitis B virus screening among patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Universal hepatitis B virus screening in patients receiving immunosuppressive therapy: a small step for the oncologists, a major advance for prevention of hepatitis B virus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Awareness of hepatitis B virus reactivation among physicians authorized to prescribe chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

The compliance of doctors with viral hepatitis B screening and antiviral prophylaxis in cancer patients receiving cytotoxic chemotherapy using a hospital-based screening reminder system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4118-1

Screening of donor and recipient prior to solid organ transplantation

21 January 2018

1 reference

12 December 2020

Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis

1 reference

12 December 2020

Screening for hepatitis B surface antigen before chemotherapy: current practice and opportunities for improvement

1 reference

12 December 2020

Screening for hepatitis B in chemotherapy patients: survey of current oncology practices

1 reference

12 December 2020

Hepatitis B screening before chemotherapy: a survey of practitioners' knowledge, beliefs, and screening practices

1 reference

12 December 2020

Vaccination and screening for infections in patients with inflammatory bowel disease: a survey of Australian gastroenterologists

1 reference

12 December 2020

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection

1 reference

12 December 2020

10.1007/S10620-016-4118-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993822%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

PubMed publication ID

26993822

1 reference